title: Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques.
abstract: Adjuvant compounds are usually included in vaccinations in order to bolster total vaccine-specific responses or to tailor an immune response toward a desired endpoint, such as the production of gamma interferon or an increase in antibody titers. While most adjuvants are studied in regard to their impact on vaccine-specific responses during and just after the vaccination period, a detailed analysis of how adjuvants skew the Th1/Th2 axis at more distant time points is not often undertaken. In the current study, we present data that suggests that adjuvants differ in their relative abilities to bolster and skew immune responses in the short term compared with more distant time points. To that end, we have employed interleukin-12 (IL-12) and IL-28B as adjuvants for DNA vaccination of rhesus macaques. While both adjuvants were able to bolster Th1-biased responses, our analysis shows that this skewing was achieved through different mechanisms. Moreover, analysis 3 months after the final immunization revealed the activity of the IL-12 adjuvant to be short lived, while the IL-28B adjuvant continued to exert its influence on the immune system. Taken together, these data suggest that the scientific and medical communities would benefit from a more detailed analysis of adjuvant function, including the determination of long-term influences of administered adjuvants.
authors.affiliation: University of Pennsylvania, 505 Stellar Chance Labs, 422 Curie Blvd., Philadelphia, PA 19104, USA.
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Morrow
authors.forename: Jian
authors.initials: J
authors.lastname: Yan
authors.forename: Panyupa
authors.initials: P
authors.lastname: Pankhong
authors.forename: Bernadette
authors.initials: B
authors.lastname: Ferraro
authors.forename: Mark G
authors.initials: MG
authors.lastname: Lewis
authors.forename: Amir S
authors.initials: AS
authors.lastname: Khan
authors.forename: Niranjan Y
authors.initials: NY
authors.lastname: Sardesai
authors.forename: David B
authors.initials: DB
authors.lastname: Weiner
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D016207:Cytokines / Q000008:administration & dosage* / Q000235:genetics; D018664:Interleukin-12 / Q000008:administration & dosage* / Q000235:genetics; D008253:Macaca mulatta; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*; D013997:Time Factors; D014612:Vaccines / Q000276:immunology*; D007378:Interleukins; D000095022:Interferon Lambda
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D018664:Interleukin-12; D014612:Vaccines; C511668:interferon-lambda protein, mouse; D007378:Interleukins; D000095022:Interferon Lambda